Synthesis and X-ray crystal structure of the calcium channel antagonist: dimethyl 1,4-dihydro-2,6-dimethyl-4-[4'-(4H-4-oxo-1-benzopyran-2-yl)phenyl]-3,5-pyridine dicarboxylate

Farmaco

Volumn 54, Issue 10, 1999, Pages 660-665

  Tunçbilek, Meral ^a   Özbey, Süheyla ^b   Kendi, Engin ^b   Yildirim, Engin ^c   Erol, Kevser ^c   Ertan, Rahmiye ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

^c ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

Author keywords

Calcium antagonistic activity; Flavonyldihydropyridine; X ray structure analysis

Indexed keywords

1,4 DIHYDROPYRIDINE DERIVATIVE; CALCIUM ANTAGONIST; FLAVONOID;

ANIMAL TISSUE; ARTICLE; CALCIUM ANTAGONISM; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; FEMALE; ILEUM; MALE; NONHUMAN; RAT; SMOOTH MUSCLE RELAXATION; X RAY CRYSTALLOGRAPHY;

ANIMALS; CALCIUM CHANNEL BLOCKERS; DIHYDROPYRIDINES; FEMALE; MALE; MOLECULAR CONFORMATION; RATS; X-RAY DIFFRACTION;

EID: 0344199932     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-827X(99)00076-2     Document Type: Article

References (28)

1. Delgado J.N., Remers W.A. Wilson and Gisvold's Texbook of Organic Medicinal and Pharmaceutical Chemistry. 1991;Lippincott, Philadelphia.
2. Langs D.A., Triggle D.J. Conformational features of calcium channel agonist and antagonist analogs of nifedipine. J. Mol. Pharmacol. 27:1985;544-548.
3. Mahmoudian M., Richards W.G. Qsar of binding of dihydropyridine-type calcium antagonists to their receptor on ileal smooth muscle preparations. J. Pharm. Pharmacol. 38:1986;272-276.
4. Ishii A., Nishida K., Oka T., Nakamizo N. Receptor binding properties of the new calcium antagonist benidipine hydrochloride. Arzneim.-Forsch./Drug Res. 38(II):1988;1677-1680.
5. Rovnyak G., Andersen N., Gougoutas J., Hedberg A., Kimball S.D., Malley M., Moreland S., Porubcan M., Pudzianowski A. Active conformation of 1,4-dihydropyridine calcium entry blockers. Effect of size of 2-aryl substituent on rotameric equilibria and receptor binding. J. Med. Chem. 34:1991;2521-2524.
6. Nayler W.G. Protection of the myocardium against postischemic reperfusion damage. The combined effect of hypothermia and nifedipine. J. Thorac. Cardiovasc. Surg. 84:1982;897-905.
7. Goldmann S., Franckowiak G., Schramm M., Thomas G., Groos R. Chromone- and thiochromone-substituted 1,4-dihydropyridine derivatives and their use in pharmaceuticals. Chem. Abstr. 102:1985;62091.
8. Gabor M. The Pharmacology of Benzopyrone Derivatives and Related Compounds. 1986;Akademiai Kado, Budapest.
9. Nardi D., Leonardi A., Pennini R., Tajana A., Cazzulani R., Testa R. New basic esters of 2-phenyl-3-methyl-4-oxo-4H-1-benzopyran-8-carboxylic acid endowed with spasmolytic properties. Arzneim.-Forsch./Drug Res. 43(I):1993;28-34.
10. Gabor M. The effect of O-(β-hydroxyethyl)-rutosides (HR) on skin capillary resistance of rats. Arzneim.-Forsch./Drug Res. 31(I):1981;442-445.
11. Nitz R.E., Pötzsch E. 3-(β-diethylamino-ethyl)-4-methyl-7-carbethoxy-methoxy-2-oxo-(1,2-chromene) - a specific, long-acting coronary dilator. Arzneim.-Forsch./Drug Res. 13:1963;243-250.
12. 2+ channel antagonists. J. Med. Chem. 26(6):1983;775-785.
13. Goldmann S., Born L., Kazda S., Pittel B., Schramm M. Synthesis, pharmacological effects, and conformation of 4,4-disubstituted 1,4-dihydropyridines. J. Med. Chem. 33:1990;1413-1418.
14. Natale N.R., Triggle D.J., Palmer R.B., Lefler B.J., Edwards W.D. 4-isoxazoyl-1,4-dihydropyridines: biological, theoretical, and structural studies. J. Med. Chem. 33:1990;2255-2259.
15. Fossheim R., Svarteng K., Mostad A., Rmming C., Shefter E., Triggle D.J. Crystal structures and pharmacological activity of calcium channel antagonists: 2,6-dimethyl-3,5-dicarbomethoxy-4-(unsubstituted, 3-methyl-, 4-methyl-, 3-nitro-, 4-nitro-, and 2,6-dinitrophenyl)-1,4-dihydropyridine. J. Med. Chem. 25:1982;126-131.
16. Hantzsch A. Ueber die Synthese pyridinartiger Verbindungen aus Acetessigätter und Aldehydammoniak. Justus Liebigs Ann. Chem. 215:1882;1-82.
17. Cramer F., Elschnig G.H. Über Einschlußverbindungen, IX. Mitteil. (1): Die blauen Jodverbindungen der Flavone. Cem. Ber. 89:1956;1-12.
18. Tuncbilek M., Ertan R. Synthesis of some 4-(3′ or 4′-(4H-4-oxo-1-benzopyran-2-yl) phenyl(-1,4-dihydropyridine derivatives as potential calcium channel antagonists. Pharmazie. 54:1999;255-259.
19. Fair C.K. MolEN: An Interactive Intelligent System for Crystal Structure Analysis. 1990;Enraf-Nonius, Delft, The Netherlands.
20. Johnson C.K. ORTEP II: Report ORNL-5138. 1976;Oak Ridge National Laboratory, Oak Ridge, TN.
21. Kendi E., Özbey S., Tunçbilek M., Ertan R., Fun H.K., Yip B.C. The structure of ethyl allyl 1,4-dihydro-2,6-dimethyl-4-[4-(4H-4-oxo-1-benzopyran-2-yl) phenyl]-3,5-pyridine dicarboxylate. J. Chem. Cryst. 24:1994;747-751.
22. Triggle A.M., Shefter E., Triggle D.J. Crystal structures of calcium channel antagonists: 2,6-dimethyl-3,5-dicarbomethoxy-4-[2-nitro-, 3-cyano-, 4-(dimethylamino)-, and 2,3,4,5,6-pentafluorophenyl]1,4-dihydropyridine. J. Med. Chem. 23:1980;1442-1445.
23. Kazda S., Garthoff B., Meyer H., Schloßmann K., Stoepel K., Towart R., Vater W., Wehinger E. Pharmacology of a new calcium antagonistic compound, isobutyl methyl 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridinedicarboxylate (nisoldipine, BAYK5552). Arzneim.-Forsch./Drug Res. 30:1980;2144-2162.
24. Şafak C., Erdemli I., Sunal R. Synthesis of some 1,4,5,6,7,8-hexahydroquinoline derivatives and their calcium antagonistic activity. Arzneim.-Forsch./Drug Res. 43:1993;1052-1055.
25. Ertan M., Balkan A., Saraç S., Uma S., Renault J.F., Rolland Y. Synthesis and calcium antagonistic activity of some new 2-thioxo-1,2,3,4-tetrahydropyrimidine derivatives. Arch. Pharm. (Weinheim). 324:1991;135-139.
26. Ashimori A., Ono T., Uchida T., Ohtaki Y., Fukaya C., Watanabe M., Yokoyama K. Novel 1,4-dihydropyridine calcium antagonists. I. Synthesis and hypotensive activity of 4-(substituted pyridyl)-1,4-dihydropyridine derivatives. Chem. Pharm. Bull. 38:1990;2446-2458.
27. Rose U. 5-Oxo-1,4-dihydropyridines: calcium modulators with partial calcium agonistic activity. J. Heterocycl. Chem. 27:1990;237-242.
28. Rose U., Drager M. Synthesis, configuration and calcium modulatory properties of enantiometrically pure 5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylates. J. Med. Chem. 35:1992;2238-2243.